drugset / Trial / NCT03596762
A Study of BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the effectiveness of BAY3427080 (NT-814), taken once a day, in the treatment of troublesome post-menopausal symptoms.
Timeline
- Start
- 2018-11-20
- Primary completion
- 2019-11-21
- Completion
- 2019-11-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elinzanetant | Small molecule | 40 mg | — |
| Subject | Elinzanetant | Small molecule | 80 mg | — |
| Subject | Elinzanetant | Small molecule | 120 mg | — |
| Subject | Elinzanetant | Small molecule | 160 mg | — |
Indications
No indication recorded.